Guangdong Taienkang Pharmaceutical Co. Ltd (301263) — Cash Flow Reinvestment Rate
Guangdong Taienkang Pharmaceutical Co. Ltd (301263) has a Cash Flow Reinvestment Rate of 2.26x as of December 2024, reinvesting CN¥202.08 Million (capex CN¥68.55 Million plus investments CN¥133.53 Million) from operating cash flow of CN¥89.33 Million. Explore capital reinvestment ratio of Guangdong Taienkang Pharmaceutical Co. L to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Guangdong Taienkang Pharmaceutical Co. Ltd Cash Flow Reinvestment Rate (2019–2024)
Historical reinvestment intensity for Guangdong Taienkang Pharmaceutical Co. Ltd across 6 annual periods. Also explore Guangdong Taienkang Pharmaceutical Co. L total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Guangdong Taienkang Pharmaceutical Co. Ltd (2019–2024)
Year-by-year capital reinvestment analysis for Guangdong Taienkang Pharmaceutical Co. Ltd. For live market cap and broader valuation context, see 301263 company net worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.26x | CN¥202.08 Million | CN¥89.33 Million | CN¥68.55 Million | ▼ -64.2% |
| 2023 | 6.32x | CN¥590.93 Million | CN¥93.53 Million | CN¥200.01 Million | ▲ +112.3% |
| 2022 | 2.98x | CN¥442.89 Million | CN¥148.81 Million | CN¥89.88 Million | ▲ +301.6% |
| 2021 | 0.74x | CN¥88.93 Million | CN¥120.02 Million | CN¥44.65 Million | ▼ -49.9% |
| 2020 | 1.48x | CN¥185.71 Million | CN¥125.53 Million | CN¥93.12 Million | ▲ +531.7% |
| 2019 | 0.23x | CN¥17.67 Million | CN¥75.44 Million | CN¥8.83 Million | — |